296.61MMarket Cap5.31P/E (TTM)
9.220High8.830Low627.13KVolume8.900Open8.950Pre Close5.69MTurnover2.13%Turnover Ratio16.71P/E (Static)32.28MShares13.86852wk High0.95P/B270.35MFloat Cap6.43652wk Low0.15Dividend TTM29.42MShs Float74.992Historical High1.63%Div YieldTTM4.36%Amplitude0.930Historical Low9.068Avg Price1Lot Size
Immersion Stock Forum
enVVeno Medical Successfully Completes Final Wave of Implants in Pre-Clinical GLP Study for enVVe
Monday, 16th December at 8:50 am
Successful Completion of All Planned Implants in GLP Study
enVVe Delivery System Demonstrates Consistent Performance
Company Maintains Timeline for IDE Application Submission by Mid-2025, Pending GLP Study Results
IRVINE, CA / ACCESSWIRE / December 16, 2024 / enVVeno Medical Corporation (NASDAQ: NVNO) ("enVVeno" or the "Company"), a compan...
Risk Level: 6 (Moderate Risk)
The risk assessment for Immersion Corporation at a score of 6 signifies moderate risk for potential investors. The company's fundamentals, such as solid profitability and reasonable P/E ratio, provide a cushion to investors; however, the absence of bullish news and lackluster sector interest increase the volatility risk. The stock's strong foundation with clear support levels counters some of the risk, but the limi...
oversold undervalued
P/L= +1.71%
loading...
loading...
No comment yet